Images
Participants
Contact
“El País” newspaper has published an article on the Barcelona BioMed Conference “Drosophila as a model in cancer”. It includes statements made by Marco Milán, ICREA researcher and head of the Development and Growth Control Laboratory, and Cayetano González, ICREA researcher and head of the Cell Division Laboratory, both at IRB Barcelona and co-organizers of this scientific meeting, which is supported by the BBVA Foundation.
The article highlights the project presented by Ross Cagan, director of the Center for Personalized Cancer Therapeutics at Mount Sinai Hospital (United States), which uses flies that have the same tumours as those found in human patients to design personalized treatments for cancer.
Read the article in “El País” (in Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
